Dyne Therapeutics

Developer of nucleic acid therapies for rare diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2017 groups116 employees language dyne-tx.com

Registered entities

Social engagement

Social engagement: 28.9K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital343%
Bank & private debt114%
Other / undisclosed343%

Hiring activity

Hires frequently

19 roles tracked across 7 of the last 12 months

10 Jun 2026 · Medical Director, US Medical Affairs · Waltham

10 Jun 2026 · Executive Director, Regulatory Affairs Advertising & Promotion · Waltham

4 Apr 2026 · Senior Manager, Scientific and Medical Education · Waltham

22 Jan 2026 · VP, Customer Experience · Joint Base Lewis-McChord

19 Jan 2026 · Director, Compliance · Waltham

Based on job postings tracked across public sources.

Recent activity

1 Jul 2026
Event
Parent Project Muscular Dystrophy Annual Conference
26 Jun 2026
Event
FSHD Connect Conference
25 Jun 2026
Event
Parent Project Muscular Dystrophy Annual Conference
Coming soon